Impact of pre-transplant malignancy on outcomes in kidney transplant recipients: an updated meta-analysis with systematic review
World Journal of Urology · 02.12.2024 · 43 (1)
DOI: 10.1007/s00345-024-05376-5 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift World Journal of Urology, online erschienen am 02.12.2024. Verfasst von He Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, No.8 Gongti South Road, Beijing, 100020, China. Hauptthemen laut MEDLINE: Kidney Transplantation, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, No.8 Gongti South Road, Beijing, 100020, China.
- Institute of Urology, Capital Medical University, Beijing, 100020, China.
- Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, No.8 Gongti South Road, Beijing, 100020, China. xiaopeng_hu@sina.com.
- Institute of Urology, Capital Medical University, Beijing, 100020, China. xiaopeng_hu@sina.com.
Zitieren
APA
Zhang, H., & Hu, X. (2024). Impact of pre-transplant malignancy on outcomes in kidney transplant recipients: an updated meta-analysis with systematic review. World Journal of Urology, 43(1). https://doi.org/10.1007/s00345-024-05376-5
Vancouver
Zhang H, Hu X. Impact of pre-transplant malignancy on outcomes in kidney transplant recipients: an updated meta-analysis with systematic review. World Journal of Urology. 2024;43(1). doi:10.1007/s00345-024-05376-5
BibTeX
@article{Zhang2024,
author = {Zhang, He and Hu, Xiaopeng},
title = {Impact of pre-transplant malignancy on outcomes in kidney transplant recipients: an updated meta-analysis with systematic review},
journal = {World Journal of Urology},
year = {2024},
volume = {43},
number = {1},
doi = {10.1007/s00345-024-05376-5}
}
EUVIMED